PENSION & WEALTH MANAGEMENT ADVISORS, INC.’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$484K Buy
33,143
+3,354
+11% +$44.3K 0.13% 106
2026
Q1
$410K Buy
29,789
+13,474
+83% +$203K 0.12% 117
2025
Q4
$294K Buy
16,315
+65
+0.4% +$1.17K 0.09% 138
2025
Q3
$301K Buy
16,250
+8,951
+123% +$141K 0.09% 120
2025
Q2
$117K Buy
+7,299
New +$130K 0.04% 186
2023
Q3
Sell
-250
Closed -$1.8K 271
2023
Q2
$1.8K Hold
250
﹤0.01% 247
2023
Q1
$1.52K Hold
250
﹤0.01% 284
2022
Q4
$1.09K Buy
+250
New +$1.12K ﹤0.01% 247

Other funds holding CLBT

PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s CLBT Position: Q2 2026 in Review

PENSION & WEALTH MANAGEMENT ADVISORS, INC. increased its Cellebrite (CLBT) stake by 11% in Q2 2026, buying an estimated $44.3K and bringing the position to 33,143 shares worth $484K. The position accounts for 0.13% of the portfolio, ranked #106.

PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in CLBT in Q4 2022 and has held it in 8 quarters since. 69 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. held 33,143 shares of Cellebrite worth $484K as of Q2 2026.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. bought 3,354 Cellebrite shares in Q2 2026, an estimated $44.3K.
  • Cellebrite made up 0.13% of PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s portfolio in Q2 2026, its #106 holding.
  • PENSION & WEALTH MANAGEMENT ADVISORS, INC. first reported a position in Cellebrite in Q4 2022 and has held it in 8 quarters since.
  • 69 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on PENSION & WEALTH MANAGEMENT ADVISORS, INC.'s 13F filing for Q2 2026, filed 7 Aug 2026.